Metabolon CEO talks move into Middle East
Research Triangle Park-based Metabolon, Inc. is expanding into the Middle East.
The company announced Wednesday that it has inked a collaboration agreement with the Anti-Doping Laboratory Qatar (ADLQ) and Weill Cornell Medicine-Qatar (WCM-Q) that will see Metabolon’s metabolomics platform used in ADLQ’s laboratory in Doha.
The platform will be used to serve both academic and nonprofit organizations, according to Metabolon, with those organizations based in 13 countries around the region.
The…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Jennifer Henderson Source Type: news
More News: Academia | Biotechnology | Health Management | Laboratory Medicine | Middle East Health | Qatar Health